Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Capital Employed (2016 - 2026)

Collegium Pharmaceutical has reported Return on Capital Employed over the past 10 years, most recently at 15.07% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 16.0% year-over-year to 15.07%; the TTM value through Dec 2025 reached 15.07%, up 16.0%, while the annual FY2025 figure was 14.72%, 428.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 15.07% at Collegium Pharmaceutical, up from 13.69% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 32.74% in Q2 2024 and troughed at 2.28% in Q1 2022.
  • A 5-year average of 13.03% and a median of 14.12% in 2021 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 2129bps in 2021 and later crashed -2143bps in 2025.
  • Year by year, Return on Capital Employed stood at 4.03% in 2021, then grew by 10bps to 4.42% in 2022, then skyrocketed by 438bps to 23.77% in 2023, then plummeted by -37bps to 14.9% in 2024, then increased by 1bps to 15.07% in 2025.
  • Business Quant data shows Return on Capital Employed for COLL at 15.07% in Q4 2025, 13.69% in Q3 2025, and 11.31% in Q2 2025.